Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01940172 |
| Title | Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer |
| Recruitment | Completed |
| Gender | female |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | TetraLogic Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| TetraLogic research site | Fresno | California | 39720 | United States | Details | |
| TetraLogic Research Site | San Luis Obispo | California | 93401 | United States | Details | |
| TetraLogic Research Site | Fairway | Kansas | 66205 | United States | Details | |
| TetraLogic Research Site | Boston | Massachusetts | 02114 | United States | Details | |
| TetraLogic Research Site | Durham | North Carolina | 27710 | United States | Details | |
| TetraLogic Research Site | Philadelphia | Pennsylvania | 19107 | United States | Details | |
| TetraLogic Research Site | Philadelphia | Pennsylvania | 19111 | United States | Details | |
| TetraLogic Research Site | Nashville | Tennessee | 37203 | United States | Details | |
| TetraLogic Research Facility | Dallas | Texas | 75201 | United States | Details |